Antony Carling (1958–2025)On 11 May 2025, Antony Carling MPharmS, aged 66 years, of Crawley, West Sussex. Mr Carling registered with the Society in 1981.…
Community pharmacies in 2024/2025 administered highest number of flu vaccinations outside of pandemic Of the 4 million flu vaccinations delivered by community pharmacies in England during the 2024/2025 flu season, data show that 11% were administered in the most deprived areas.…
Case-based learning: understanding and managing levetiracetam-induced psychiatric symptoms This article highlights the psychiatric adverse effects of levetiracetam, emphasising the importance of recognising these effects rather than attributing them to an organic diagnosis.…
NHS App to be used to recruit patients for clinical trials The Department of Health and Social Care said it is particularly encouraging underrepresented groups, such as people from ethnic minority backgrounds, to sign up to trials.…
How we reduced polypharmacy by 1.6 medicines per patient in a care home A pharmacist-led study revealed statistical significance in the reduction of medicines and anticholinergic burden, following structured medication reviews in care home patients.…
Amandeep Doll appointed as RPS director for England The Royal Pharmaceutical Society said Amandeep Doll will begin the role of director for England in August 2025 following a “competitive and rigorous” recruitment process.…
NICE recommends ‘breakthrough’ therapy for blood cancer Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…
MHRA publishes ‘world first’ decentralised manufacturing guidance The guidance will inform the manufacture of medicines with a short shelf-life or highly personalised medicines at sites within or in close proximity to hospitals.…
Recognising adverse events and using the Yellow Card system An overview of how to identify, manage and report adverse events.…
Yellow Card reporting in East London NHS Foundation TrustThe Yellow Card scheme is a system for reporting adverse drug reactions (ADRs) from medicines or adverse incidents with medical devices in the UK, ensuring that these products are safe for both healthcare professionals and patients1–3. Reporting these issues helps the MHRA to identify new sa…
